Vardakas, K. Z., Polyzos, K. A., Patouni, K., et al.: Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. Int. J. Antimicrob. Agents, 2012, 40 , 1
vancomycin, ampicillin, and high-level aminoglycoside resistance (HLAR). Materials and Methods Sampling Fecal swabs were collected from 287 clinically healthy dogs, which were regularly kept indoor, strictly in
. McBride SJ , Upton A , Roberts SA : Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia – a five-year retrospective review . Eur J
Resist. 2009 15 129 132 Hiramatsu, K.: Vancomycin-resistant Staphylococcus aureus : A new
difficile colitis with oral vancomycin: comparison of two dosage regimens. Am. J. Med., 1989, 86 , 15–19. Kauffman C. Treatment of antibiotic-associated Clostridium difficile colitis
Ltd, Liverpool, United Kingdom), chosen on the basis of the common susceptibility profile of the species. Determination of Minimum Inhibitory Concentration (MIC) value Against staphylococci, vancomycin and oxacillin do not give reliable results with
biofilm was thicker, contained more pillar and channel structures compared with the control [ 30 ]. Kafil et al. [ 31 ] investigated the effects of ampicillin (AMP), vancomycin (VAN), GEN, and ceftizoxime antibiotics on biofilm formation and gene
treatment options. Front Cell Infect Microbiol. 2017; 7: 55. 10.3389/fcimb.2017.00055 . 6 Benamu E, Deresinski S. Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant
/ml) [tetracycline (30 μg), doxycycline (30 μg), gentamicin (10 μg), erythromycin (15 μg), ciprofloxacin (5 μg), clindamycin (30 μg), chloramphenicol (30 μg), amikacin (10 μg), co-trimoxazole (25 μg), and vancomycin (30 μg)] were used to determine antibiogram
. , Richter , A. , Popp , C. and Hafez , H. M. ( 2013 ): Occurrence of vancomycin-resistant enterococci in turkey flocks . Poult. Sci. 92 , 346 – 351 . Szeleszczuk , P. , Dolka
